Although activating mutations and gene amplifications of Egfr are low frequency occurrences in breast cancer, Egfr expression can be enhanced by increased gene copy number due to polysomy, and enhanced expression of Egfr in primary tumors is associated with increased metastasis and decreased survival of TNBC patients [77, 78]. Here, EGFR is linked to breast cancer.